Philippe Gaulard

Université Paris Est
Creteil, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 198 publications

Extranodal natural killer/T-cell lymphoma: From fatal to curable.

Extranodal natural killer/T-cell lymphoma: From fatal to curable.

Journal: CA: a cancer journal for clinicians
Published: March 04, 2026

Genomic loss of MLH1/PMS2 loci defines a mismatch repair deficient subgroup in monomorphic epitheliotropic intestinal T-cell lymphoma.

Genomic loss of MLH1/PMS2 loci defines a mismatch repair deficient subgroup in monomorphic epitheliotropic intestinal T-cell lymphoma.

Journal: Blood cancer journal
Published: January 23, 2026

Diagnostic approach to non-cutaneous T-cell lymphomas in 2025: What pitfalls and how should they be classified?

Diagnostic approach to non-cutaneous T-cell lymphomas in 2025: What pitfalls and how should they be classified?

Journal: Annales de pathologie
Published: December 30, 2025

Correction: Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma.

Correction: Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma.

Journal: Leukemia
Published: November 20, 2025

Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma.

Divergent molecular pathways drive monomorphic epitheliotropic and enteropathy-associated intestinal T-cell lymphoma.

Journal: Leukemia
Published: July 28, 2025

Follicular Helper T-Cell Lymphomas With Epstein-Barr Virus-Positive Neoplastic Cells: A Rare Scenario With Diagnostic Implications.

Follicular Helper T-Cell Lymphomas With Epstein-Barr Virus-Positive Neoplastic Cells: A Rare Scenario With Diagnostic Implications.

Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: June 04, 2025

Risk stratification of patients with diffuse large B-cell lymphoma using plasma NMR-based metabolomics at diagnosis.

Risk stratification of patients with diffuse large B-cell lymphoma using plasma NMR-based metabolomics at diagnosis.

Journal: Blood advances
Published: May 23, 2025

Scavenging Reactive Oxygen Species by Cerium Oxide Nanoparticles Prevents Death in a Peripheral T Cell Lymphoma Preclinical Mouse Model.

Scavenging Reactive Oxygen Species by Cerium Oxide Nanoparticles Prevents Death in a Peripheral T Cell Lymphoma Preclinical Mouse Model.

Journal: ACS nano
Published: May 09, 2025

Distribution reappraisal of peripheral T- and NK-cell lymphoma entities through the French Lymphopath network database.

Distribution reappraisal of peripheral T- and NK-cell lymphoma entities through the French Lymphopath network database.

Journal: HemaSphere
Published: April 15, 2025

Targeting of CD28 and CD38 as a potential novel therapeutic strategy for peripheral T-cell lymphomas.

Targeting of CD28 and CD38 as a potential novel therapeutic strategy for peripheral T-cell lymphomas.

Journal: Scientific reports
Published: April 04, 2025

Follicular Helper T-cell Lymphoma With Hodgkin/Reed-Sternberg-Like Cells Versus Classic Hodgkin Lymphoma: A Comparative Study.

Follicular Helper T-cell Lymphoma With Hodgkin/Reed-Sternberg-Like Cells Versus Classic Hodgkin Lymphoma: A Comparative Study.

Journal: The American journal of surgical pathology
Published: January 06, 2025

Brentuximab vedotin addition to gemcitabine in relapsed or refractory peripheral T-cell lymphoma: a LYSA phase 2 study.

Brentuximab vedotin addition to gemcitabine in relapsed or refractory peripheral T-cell lymphoma: a LYSA phase 2 study.

Journal: Blood advances
Published: January 02, 2025
Showing 1-12 of 198

Last Updated: 09/26/2026